314 related articles for article (PubMed ID: 25304686)
21. Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach.
Shahab SW; Matyunina LV; Mezencev R; Walker LD; Bowen NJ; Benigno BB; McDonald JF
PLoS One; 2011; 6(7):e22508. PubMed ID: 21811625
[TBL] [Abstract][Full Text] [Related]
22. Regulatory Mechanism of MicroRNA Expression in Cancer.
Ali Syeda Z; Langden SSS; Munkhzul C; Lee M; Song SJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138313
[TBL] [Abstract][Full Text] [Related]
23. microRNAs exhibit high frequency genomic alterations in human cancer.
Zhang L; Huang J; Yang N; Greshock J; Megraw MS; Giannakakis A; Liang S; Naylor TL; Barchetti A; Ward MR; Yao G; Medina A; O'brien-Jenkins A; Katsaros D; Hatzigeorgiou A; Gimotty PA; Weber BL; Coukos G
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9136-41. PubMed ID: 16754881
[TBL] [Abstract][Full Text] [Related]
24. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic control of autophagy by microRNAs in ovarian cancer.
Titone R; Morani F; Follo C; Vidoni C; Mezzanzanica D; Isidoro C
Biomed Res Int; 2014; 2014():343542. PubMed ID: 24877083
[TBL] [Abstract][Full Text] [Related]
26. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
27. Network analysis of microRNAs and their regulation in human ovarian cancer.
Schmeier S; Schaefer U; Essack M; Bajic VB
BMC Syst Biol; 2011 Nov; 5():183. PubMed ID: 22050994
[TBL] [Abstract][Full Text] [Related]
28. Identifying microRNA/mRNA dysregulations in ovarian cancer.
Miles GD; Seiler M; Rodriguez L; Rajagopal G; Bhanot G
BMC Res Notes; 2012 Mar; 5():164. PubMed ID: 22452920
[TBL] [Abstract][Full Text] [Related]
29. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
[TBL] [Abstract][Full Text] [Related]
30. Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Laios A; O'Toole S; Flavin R; Martin C; Kelly L; Ring M; Finn SP; Barrett C; Loda M; Gleeson N; D'Arcy T; McGuinness E; Sheils O; Sheppard B; O' Leary J
Mol Cancer; 2008 Apr; 7():35. PubMed ID: 18442408
[TBL] [Abstract][Full Text] [Related]
31. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
[TBL] [Abstract][Full Text] [Related]
32. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer.
Dou YD; Huang T; Wang Q; Shu X; Zhao SG; Li L; Liu T; Lu G; Chan WY; Liu HB
Biochem Biophys Res Commun; 2018 Jan; 496(1):191-198. PubMed ID: 29307835
[TBL] [Abstract][Full Text] [Related]
33. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
Fu X; Cui Y; Yang S; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide analysis of microRNA and mRNA expression signatures in cancer.
Li MH; Fu SB; Xiao HS
Acta Pharmacol Sin; 2015 Oct; 36(10):1200-11. PubMed ID: 26299954
[TBL] [Abstract][Full Text] [Related]
36. Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Ray M; Ruffalo MM; Bar-Joseph Z
Genes Chromosomes Cancer; 2019 Jan; 58(1):34-42. PubMed ID: 30285311
[TBL] [Abstract][Full Text] [Related]
37. miRNAs and ovarian cancer: An overview.
Deb B; Uddin A; Chakraborty S
J Cell Physiol; 2018 May; 233(5):3846-3854. PubMed ID: 28703277
[TBL] [Abstract][Full Text] [Related]
38. The role of microRNAs in ovarian cancer initiation and progression.
Li SD; Zhang JR; Wang YQ; Wan XP
J Cell Mol Med; 2010 Sep; 14(9):2240-9. PubMed ID: 20345848
[TBL] [Abstract][Full Text] [Related]
39. Recent trends in targeting miRNAs for cancer therapy.
Shah V; Shah J
J Pharm Pharmacol; 2020 Dec; 72(12):1732-1749. PubMed ID: 32783235
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression and identification of putative miRNA targets in ovarian cancer.
Dahiya N; Sherman-Baust CA; Wang TL; Davidson B; Shih IeM; Zhang Y; Wood W; Becker KG; Morin PJ
PLoS One; 2008 Jun; 3(6):e2436. PubMed ID: 18560586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]